Anse compatibile cu endoscoapele Olympus seria 185/90
Information about customer
Title
IMSP Institutul Oncologic
IDNO
1003600151023
Address
MOLDOVA,
locality,
str. Testemitanu, 30,
MD 2025
The contact person
Adam Ana,
aniusha_adam@mail.ru
Purchase data
ID
ocds-b3wdp1-MD-1652858536404
Title
Anse compatibile cu endoscoapele Olympus seria 185/90
Note
CPV Code
33100000-1 - Echipamente medicale
Rationale
List of funding sources
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1652858803034
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1652858537255
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1653304679231
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1653304679356
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1654765115239
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1654765114759
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1654765115060
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1654765114880
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1656922492531
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1656922492722
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1656922492375
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1656922492900
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1659336787734
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1659336787554
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1659336787427
IBAN
None
Funding source cost
30750.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1652858536404-FS-1659336787923
IBAN
None
Status Planning
Start the procedure:
1 Jan 2022
1 Jan 2023
Date of publication: 18 May 2022 10:22
Date of last modifications: 1 Aug 2022 09:53